Earnings Forecast
搜索文档
Super Micro Computer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga· 2025-11-05 01:54
Super Micro Computer, Inc. (NASDAQ:SMCI) will release earnings results for the first quarter, after the closing bell on Tuesday, Nov. 4.Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at 39 cents per share, down from 74 cents per share in the year-ago period. The consensus estimate for Super Micro Computer's quarterly revenue is $5.8 billion, compared to $5.94 billion a year earlier, according to data from Benzinga Pro.On Oct. 29, Super Micro Computer announced the creat ...
Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga· 2025-11-04 15:49
Pfizer Inc. (NYSE:PFE) will release earnings results for the third quarter before the opening bell on Tuesday, Nov. 4.Analysts expect the health care company to report quarterly earnings at 64 cents per share, down from $1.06 per share in the year-ago period. The consensus estimate for Pfizer’s quarterly revenue is $16.52 billion, down from $17.7 billion a year earlier, according to Benzinga Pro.On Friday, Pfizer filed a lawsuit against Metsera, Inc. (NASDAQ:MTSR), its Board of Directors, and Novo Nordisk ( ...
Lear Analysts Increase Their Forecasts After Upbeat Results - Lear (NYSE:LEA)
Benzinga· 2025-11-04 03:58
Lear Corporation (NYSE:LEA) reported upbeat earnings for the third quarter on Friday.The company posted quarterly earnings of $2.79 per share which beat the analyst consensus estimate of $2.73 per share. The company reported quarterly sales of $5.680 billion which beat the analyst consensus estimate of $5.600 billion.Lear raised its FY2025 sales guidance from $22.470 billion-$23.070 billion to $22.850 billion-$23.150 billion.“Lear continued its solid momentum in the third quarter, delivering one of the high ...
Lear Analysts Increase Their Forecasts After Upbeat Results
Benzinga· 2025-11-04 03:58
Lear Corporation (NYSE:LEA) reported upbeat earnings for the third quarter on Friday.The company posted quarterly earnings of $2.79 per share which beat the analyst consensus estimate of $2.73 per share. The company reported quarterly sales of $5.680 billion which beat the analyst consensus estimate of $5.600 billion.Lear raised its FY2025 sales guidance from $22.470 billion-$23.070 billion to $22.850 billion-$23.150 billion.“Lear continued its solid momentum in the third quarter, delivering one of the high ...
These Analysts Boost Their Forecasts On nVent Electric Following Upbeat Q3 Results
Benzinga· 2025-11-04 03:46
nVent Electric plc (NYSE:NVT) reported its third-quarter results on Friday that topped street estimates.The company reported adjusted earnings of 91 cents per share, up 44% from the prior year period, surpassing analysts' expectations of 88 cents.Net sales climbed to $1.05 billion, up 35% from a year earlier and ahead of estimates of $1.01 billion, while organic sales growth was 16% for the quarter. The company's adjusted operating income rose 27% to $213 million.nVent Electric raised its full-year 2025 out ...
Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga· 2025-11-04 03:23
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the first quarter, after the closing bell on Monday, Nov. 3.Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.58 per share, up from $4.38 per share in the year-ago period. The consensus estimate for Vertex Pharmaceuticals' quarterly revenue is $3.06 billion, compared to $2.77 billion a year earlier, according to data from Benzinga Pro.On Aug. 4, Vertex Pharmaceuticals posted better-th ...
Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Vertex Pharmaceuticals (NASDAQ:VRTX)
Benzinga· 2025-11-04 03:23
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the first quarter, after the closing bell on Monday, Nov. 3.Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.58 per share, up from $4.38 per share in the year-ago period. The consensus estimate for Vertex Pharmaceuticals' quarterly revenue is $3.06 billion, compared to $2.77 billion a year earlier, according to data from Benzinga Pro.On Aug. 4, Vertex Pharmaceuticals posted better-th ...
Charter Communications Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Charter Communications (NASDAQ:CHTR)
Benzinga· 2025-10-31 15:59
财报预期 - 公司将于10月31日盘前公布第三季度财报 [1] - 市场预期季度每股收益为9.29美元 较去年同期的8.82美元有所增长 [1] - 市场预期季度营收为137.5亿美元 略低于去年同期的137.9亿美元 [1] 近期业绩与股价表现 - 第二季度营收同比增长0.6%至137.7亿美元 超出市场预期的137.6亿美元 [2] - 公司股价在财报公布前下跌4.4% 收于230.92美元 [2] 分析师评级与目标价 - Citigroup分析师给予买入评级 目标价325美元 准确率74% [5] - Goldman Sachs分析师给予卖出评级 目标价223美元 准确率75% [5] - Wells Fargo分析师给予持有评级 目标价300美元 准确率65% [5] - UBS分析师维持中性评级 但将目标价从425美元下调至355美元 准确率76% [5] - Morgan Stanley分析师维持持有评级 并将目标价从385美元上调至415美元 准确率74% [5]
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Colgate-Palmolive (NYSE:CL)
Benzinga· 2025-10-31 15:50
即将发布的第三季度财报 - 高露洁-棕榄公司计划于10月31日周五开盘前公布第三季度财报 [1] - 市场预期公司第三季度每股收益为0.89美元,低于去年同期0.91美元的水平 [1] - 市场预期公司第三季度营收为51.3亿美元,高于去年同期50.3亿美元的水平 [1] 近期财务表现与市场反应 - 公司在8月1日公布的第二季度调整后每股收益为0.92美元,超出市场预期的0.89美元 [2] - 在财报公布后的一个周四,公司股价上涨1%,收于76.51美元 [2] 分析师评级与目标价调整 - 多位分析师在近期维持了对公司的评级,但普遍下调了目标价 [4] - 雷蒙德·詹姆斯分析师Olivia Tong维持“跑赢大盘”评级,目标价从105美元下调至95美元 [4] - 摩根大通分析师Andrea Teixeira维持“增持”评级,目标价从95美元下调至88美元 [4] - 派珀·桑德勒分析师Michael Lavery给予“中性”评级,目标价为84美元 [4] - 巴克莱分析师Lauren Lieberman维持“持股观望”评级,目标价从87美元下调至82美元 [4] - 摩根士丹利分析师Dara Mohsenian维持“增持”评级,目标价从104美元下调至96美元 [4]
Exxon Mobil Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga· 2025-10-31 15:19
财报预期 - 公司将于10月31日周五开盘前公布第三季度财报 [1] - 市场预期公司季度每股收益为1.82美元,低于去年同期1.92美元 [1] - 市场预期公司季度营收为877.1亿美元,低于去年同期900.2亿美元 [1] 近期股价与行业动态 - 股票近期受益于行业整体上涨,因美国对俄罗斯石油生产商的制裁推高了原油价格,这直接提升了公司的盈利能力 [2] - 公司股价在周四下跌1.5%,收于114.69美元 [2] 分析师观点汇总 - Wells Fargo分析师于2025年10月17日首次覆盖公司股票,给予“增持”评级,目标价156美元 [5] - Melius Research分析师于2025年8月20日首次覆盖公司股票,给予“持有”评级,目标价111美元 [5] - Piper Sandler分析师于2025年8月18日维持“增持”评级,并将目标价从134美元上调至145美元 [5] - Goldman Sachs分析师于2025年8月8日重申“中性”评级,目标价117美元 [5] - Morgan Stanley分析师于2025年8月4日维持“增持”评级,并将目标价从134美元上调至135美元 [5]